Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.

Nickson C, Procopio P, Velentzis LS, Carr S, Devereux L, Mann GB, James P, Lee G, Wellard C, Campbell I.

Breast Cancer Res. 2018 Dec 20;20(1):155. doi: 10.1186/s13058-018-1084-x.

2.

Treatment Intensity Differences According to Participation in a Population Screening Program.

Mann GB, Nickson C, Elder K.

Ann Surg Oncol. 2018 Dec 18. doi: 10.1245/s10434-018-07113-w. [Epub ahead of print] No abstract available.

PMID:
30565041
3.

A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer.

Lindeman GJ, Lok SW, Whittle JR, Vaillant F, Teh CE, Lo LL, Policheni AN, Bergin ART, Desai J, Ftouni S, Gandolfo LC, Liew D, Liu HK, Mann GB, Moodie K, Murugasu A, Pal B, Roberts AW, Rosenthal MA, Shackleton K, Silva MJ, Siow ZR, Smyth GK, Taylor L, Travers A, Yeo B, Yeung MM, Zivanovic Bujak A, Dawson SJ, Gray DHD, Visvader JE.

Cancer Discov. 2018 Dec 5. pii: CD-18-1151. doi: 10.1158/2159-8290.CD-18-1151. [Epub ahead of print]

PMID:
30518523
4.

Consumer and clinician perspectives on personalising breast cancer prevention information.

Keogh LA, Steel E, Weideman P, Butow P, Collins IM, Emery JD, Mann GB, Bickerstaffe A, Trainer AH, Hopper LJ, Phillips KA.

Breast. 2018 Nov 7;43:39-47. doi: 10.1016/j.breast.2018.11.002. [Epub ahead of print]

PMID:
30445378
5.

ASO Author Reflections: Impact of Breast Cancer Screening Beyond Mortality Reductions.

Elder K, Nickson C, Mann GB.

Ann Surg Oncol. 2018 Nov 9. doi: 10.1245/s10434-018-7001-9. [Epub ahead of print] No abstract available.

PMID:
30414033
6.

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable.

Chin-Lenn L, De Boer RH, Segelov E, Marx GM, Hughes TM, McCarthy NJ, White SC, Foo SS, Rutovitz JJ, Della-Fiorentina S, Jennens R, Antill YC, Tsoi D, Cronk MF, Lombard JM, Kiely BE, Chirgwin JH, Gorelik A, Mann GB.

Asia Pac J Clin Oncol. 2018 Dec;14(6):410-416. doi: 10.1111/ajco.13075. Epub 2018 Sep 30.

PMID:
30270527
7.

Factors influencing reoperation following breast-conserving surgery.

Philpott A, Wong J, Elder K, Gorelik A, Mann GB, Skandarajah A.

ANZ J Surg. 2018 Sep;88(9):922-927. doi: 10.1111/ans.14467. Epub 2018 May 15.

PMID:
29763991
8.

Spotlight on the utility of the Oncotype DX® breast cancer assay.

Siow ZR, De Boer RH, Lindeman GJ, Mann GB.

Int J Womens Health. 2018 Feb 21;10:89-100. doi: 10.2147/IJWH.S124520. eCollection 2018. Review.

9.

Uptake of adjuvant breast cancer treatments recommended by multi-disciplinary meetings.

Pattanasri M, Elder K, Nickson C, Cooke S, Machalek D, Rose A, Mou A, Collins JP, Park A, De Boer R, Phillips C, Pridmore V, Farrugia H, Mann GB.

ANZ J Surg. 2018 Jan 23. doi: 10.1111/ans.14368. [Epub ahead of print]

PMID:
29363225
10.

Study protocol for Enhancing Parenting In Cancer (EPIC): development and evaluation of a brief psycho-educational intervention to support parents with cancer who have young children.

Stafford L, Sinclair M, Turner J, Newman L, Wakefield C, Krishnasamy M, Mann GB, Gilham L, Mason K, Rauch P, Cannell J, Schofield P.

Pilot Feasibility Stud. 2017 Dec 11;3:72. doi: 10.1186/s40814-017-0215-y. eCollection 2017.

11.

Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features.

Hendry S, Pang JB, Byrne DJ, Lakhani SR, Cummings MC, Campbell IG, Mann GB, Gorringe KL, Fox SB.

Clin Cancer Res. 2017 Sep 1;23(17):5210-5217. doi: 10.1158/1078-0432.CCR-17-0743. Epub 2017 Jun 13.

12.

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.

Pang JB, Savas P, Fellowes AP, Mir Arnau G, Kader T, Vedururu R, Hewitt C, Takano EA, Byrne DJ, Choong DY, Millar EK, Lee CS, O'Toole SA, Lakhani SR, Cummings MC, Mann GB, Campbell IG, Dobrovic A, Loi S, Gorringe KL, Fox SB.

Mod Pathol. 2017 Jul;30(7):952-963. doi: 10.1038/modpathol.2017.21. Epub 2017 Mar 24.

13.

Surgeon knows best versus breast cancer surgical clinical trial equipoise: a plea for the sake of future trials.

Spillane AJ, Mann GB.

ANZ J Surg. 2017 Mar;87(3):111-112. doi: 10.1111/ans.13831. No abstract available.

PMID:
28253558
14.

Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.

Skandarajah AR, Thomas S, Shackleton K, Chin-Lenn L, Lindeman GJ, Mann GB.

Breast. 2017 Apr;32:93-97. doi: 10.1016/j.breast.2017.01.002. Epub 2017 Jan 18.

PMID:
28107734
15.

Patient-reported outcomes in ductal carcinoma in situ: A systematic review.

King MT, Winters ZE, Olivotto IA, Spillane AJ, Chua BH, Saunders C, Westenberg AH, Mann GB, Burnett P, Butow P, Rutherford C.

Eur J Cancer. 2017 Jan;71:95-108. doi: 10.1016/j.ejca.2016.09.035. Epub 2016 Dec 15. Review.

PMID:
27987454
16.

Laparoscopic or open appendicectomy for suspected appendicitis in pregnancy and evaluation of foetal outcome in Australia.

Winter NN, Guest GD, Bozin M, Thomson BN, Mann GB, Tan SBM, Clark DA, Daruwalla J, Muralidharan V, Najan N, Pitcher ME, Vilhelm K, Cox MR, Lane SE, Watters DA.

ANZ J Surg. 2017 May;87(5):334-338. doi: 10.1111/ans.13750. Epub 2016 Sep 6.

PMID:
27598241
17.

RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.

Nolan E, Vaillant F, Branstetter D, Pal B, Giner G, Whitehead L, Lok SW, Mann GB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Rohrbach K, Huang LY, Soriano R, Smyth GK, Dougall WC, Visvader JE, Lindeman GJ.

Nat Med. 2016 Aug;22(8):933-9. doi: 10.1038/nm.4118. Epub 2016 Jun 20.

PMID:
27322743
18.

Management of Early Node-Positive Breast Cancer in Australia: A Multicentre Study.

Gannan E, Khoo J, Nightingale S, Suhardja TS, Lippey J, Keane H, Tan KJ, Clouston D, Gorelik A, Mann GB; Melbourne Breast Group.

Breast J. 2016 Jul;22(4):413-9. doi: 10.1111/tbj.12595. Epub 2016 Apr 20.

PMID:
27095381
19.

Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer.

Stafford L, Komiti A, Bousman C, Judd F, Gibson P, Mann GB, Quinn M.

Breast. 2016 Apr;26:100-5. doi: 10.1016/j.breast.2016.01.008. Epub 2016 Feb 17.

PMID:
27017248
20.

A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.

Zdenkowski N, Butow P, Mann GB, Fewster S, Beckmore C, Isaacs R, Douglas C, Boyle FM.

Intern Med J. 2016 Jun;46(6):677-83. doi: 10.1111/imj.13049.

PMID:
26929045
21.

iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.

Collins IM, Bickerstaffe A, Ranaweera T, Maddumarachchi S, Keogh L, Emery J, Mann GB, Butow P, Weideman P, Steel E, Trainer A, Bressel M, Hopper JL, Cuzick J, Antoniou AC, Phillips KA.

Breast Cancer Res Treat. 2016 Feb;156(1):171-82. doi: 10.1007/s10549-016-3726-y. Epub 2016 Feb 24.

22.

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

Zdenkowski N, Forbes JF, Boyle FM, Kannourakis G, Gill PG, Bayliss E, Saunders C, Della-Fiorentina S, Kling N, Campbell I, Mann GB, Coates AS, Gebski V, Davies L, Thornton R, Reaby L, Cuzick J, Green M; Australia and New Zealand Breast Cancer Trials Group.

Ann Oncol. 2016 May;27(5):806-12. doi: 10.1093/annonc/mdw055. Epub 2016 Feb 9.

PMID:
26861603
23.

Copy number analysis of ductal carcinoma in situ with and without recurrence.

Gorringe KL, Hunter SM, Pang JM, Opeskin K, Hill P, Rowley SM, Choong DY, Thompson ER, Dobrovic A, Fox SB, Mann GB, Campbell IG.

Mod Pathol. 2015 Sep;28(9):1174-84. doi: 10.1038/modpathol.2015.75. Epub 2015 Jun 19.

24.

Solitary pituitary metastasis from HER2-positive breast cancer.

Kam J, Kam J, Mann GB, Phillips C, Wentworth JM, King J, Lindeman GJ.

Asia Pac J Clin Oncol. 2017 Apr;13(2):e181-e184. doi: 10.1111/ajco.12353. Epub 2015 Apr 14.

PMID:
25869477
25.

Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?

Phillips KA, Steel EJ, Collins I, Emery J, Pirotta M, Mann GB, Butow P, Hopper JL, Trainer A, Moreton J, Antoniou AC, Cuzick J, Keogh L.

Aust J Prim Health. 2016;22(3):255-261. doi: 10.1071/PY14156.

PMID:
25705982
26.

Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome.

Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M.

Support Care Cancer. 2015 Aug;23(8):2215-24. doi: 10.1007/s00520-014-2571-y. Epub 2015 Jan 6.

PMID:
25559036
27.

Predictors of outcome after surgery for gastric cancer in a Western cohort.

Pattison S, Mann GB, Crosthwaite G, Lade S, Mitchell C, Leong T, Busuttil RA, Boussioutas A.

ANZ J Surg. 2016 Jun;86(6):469-74. doi: 10.1111/ans.12915. Epub 2014 Nov 12.

PMID:
25388659
28.

Status of sentinel node biopsy - response.

Mann GB.

Surgeon. 2015 Feb;13(1):60. doi: 10.1016/j.surge.2014.06.011. Epub 2014 Aug 1. No abstract available.

PMID:
25087503
29.

Assessing and managing breast cancer risk: clinicians' current practice and future needs.

Collins IM, Steel E, Mann GB, Emery JD, Bickerstaffe A, Trainer A, Butow P, Pirotta M, Antoniou AC, Cuzick J, Hopper J, Phillips KA, Keogh LA.

Breast. 2014 Oct;23(5):644-50. doi: 10.1016/j.breast.2014.06.014. Epub 2014 Jul 4.

PMID:
24998452
30.

Sentinel node biopsy in breast cancer revisited.

Omair M, Al-Azawi D, Mann GB.

Surgeon. 2014 Jun;12(3):158-65. doi: 10.1016/j.surge.2013.12.007. Epub 2014 Feb 16. Review.

PMID:
24548701
31.

Comparison of outcomes after laparoscopic versus posterior retroperitoneoscopic adrenalectomy: a pilot study.

Cabalag MS, Mann GB, Gorelik A, Miller JA.

Surg Laparosc Endosc Percutan Tech. 2014 Feb;24(1):62-6. doi: 10.1097/SLE.0b013e31828fa71f.

PMID:
24487160
32.

Posterior retroperitoneoscopic adrenalectomy: outcomes and lessons learned from initial 50 cases.

Cabalag MS, Mann GB, Gorelik A, Miller JA.

ANZ J Surg. 2015 Jun;85(6):478-82. doi: 10.1111/ans.12508. Epub 2014 Jan 20.

PMID:
24438017
33.

Women's reflections on fertility and motherhood after breast cancer and its treatment.

Kirkman M, Winship I, Stern C, Neil S, Mann GB, Fisher JR.

Eur J Cancer Care (Engl). 2014 Jul;23(4):502-13. doi: 10.1111/ecc.12163. Epub 2014 Jan 14.

PMID:
24417674
34.

Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer.

Stafford L, Judd F, Gibson P, Komiti A, Quinn M, Mann GB.

Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):74-80. doi: 10.1016/j.genhosppsych.2013.08.010. Epub 2013 Nov 5.

PMID:
24200105
35.

The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancer.

de Boer RH, Baker C, Speakman D, Chao CY, Yoshizawa C, Mann GB.

Med J Aust. 2013 Aug 5;199(3):205-8.

PMID:
23909545
36.

Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.

Kam JK, Naidu P, Rose AK, Mann GB.

J Med Imaging Radiat Oncol. 2013 Aug;57(4):400-6. doi: 10.1111/1754-9485.12030. Epub 2013 Jan 14.

PMID:
23870334
37.

Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer.

Vaillant F, Merino D, Lee L, Breslin K, Pal B, Ritchie ME, Smyth GK, Christie M, Phillipson LJ, Burns CJ, Mann GB, Visvader JE, Lindeman GJ.

Cancer Cell. 2013 Jul 8;24(1):120-9. doi: 10.1016/j.ccr.2013.06.002.

38.

Profile and predictors of long-term morbidity in breast cancer survivors.

Tian Y, Schofield PE, Gough K, Mann GB.

Ann Surg Oncol. 2013 Oct;20(11):3453-60. doi: 10.1245/s10434-013-3004-8. Epub 2013 May 24.

PMID:
23702642
39.

Improving the impact of didactic resident training with online spaced education.

Gyorki DE, Shaw T, Nicholson J, Baker C, Pitcher M, Skandarajah A, Segelov E, Mann GB.

ANZ J Surg. 2013 Jun;83(6):477-80. doi: 10.1111/ans.12166. Epub 2013 Apr 26.

PMID:
23617607
40.

Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.

Matsumoto M, Roufail S, Inder R, Caesar C, Karnezis T, Shayan R, Farnsworth RH, Sato T, Achen MG, Mann GB, Stacker SA.

Clin Exp Metastasis. 2013 Aug;30(6):819-32. doi: 10.1007/s10585-013-9581-x. Epub 2013 Apr 17.

PMID:
23591595
41.

Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.

Gatzemeier W, Mann GB.

Breast. 2013 Jun;22(3):211-6. doi: 10.1016/j.breast.2013.02.001. Epub 2013 Mar 9. Review.

PMID:
23478200
42.

Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months.

Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M.

Psychooncology. 2013 Sep;22(9):2071-8. doi: 10.1002/pon.3253. Epub 2013 Feb 12.

PMID:
23401315
43.

Fertility management after breast cancer diagnosis: a qualitative investigation of women's experiences of and recommendations for professional care.

Kirkman M, Stern C, Neil S, Winship I, Mann GB, Shanahan K, Missen D, Shepherd H, Fisher JR.

Health Care Women Int. 2013;34(1):50-67. doi: 10.1080/07399332.2012.735729.

PMID:
23216096
44.

Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis.

Shayan R, Inder R, Karnezis T, Caesar C, Paavonen K, Ashton MW, Mann GB, Taylor GI, Achen MG, Stacker SA.

Clin Exp Metastasis. 2013 Mar;30(3):345-56. doi: 10.1007/s10585-012-9541-x. Epub 2012 Nov 3.

PMID:
23124573
45.

Endocrine surgeon-performed US guided thyroid FNAC is accurate and efficient.

Al-azawi D, Mann GB, Judson RT, Miller JA.

World J Surg. 2012 Aug;36(8):1947-52. doi: 10.1007/s00268-012-1592-2.

PMID:
22526037
46.

The role of magnetic resonance imaging in early breast cancer.

Skandarajah AR, Mann GB.

Asia Pac J Clin Oncol. 2012 Mar;8(1):24-30. doi: 10.1111/j.1743-7563.2012.01517.x. Review.

PMID:
22369441
47.

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma.

Johnson CE, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, Hill P, Mann GB, Campbell IG.

Breast Cancer Res Treat. 2012 Jun;133(3):889-98. doi: 10.1007/s10549-011-1835-1. Epub 2011 Nov 4.

PMID:
22052326
48.

Breast conservation versus mastectomy in triple-negative breast cancer: two steps forward, one step back?

Trainer AH, James PA, Mann GB, Lindeman GJ.

J Clin Oncol. 2011 Dec 10;29(35):4722-3; author reply 4723-4. doi: 10.1200/JCO.2011.38.9684. Epub 2011 Oct 31. No abstract available.

PMID:
22042938
49.

Outcomes of screening-detected ductal carcinoma in situ treated with wide excision alone.

Fong J, Kurniawan ED, Rose AK, Mou A, Collins JP, Miller JA, Mann GB.

Ann Surg Oncol. 2011 Dec;18(13):3778-84. doi: 10.1245/s10434-011-1748-6. Epub 2011 Jun 1.

PMID:
21630124
50.

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.

Kurniawan ED, Rose A, Mou A, Buchanan M, Collins JP, Wong MH, Miller JA, Mann GB.

Arch Surg. 2010 Nov;145(11):1098-104. doi: 10.1001/archsurg.2010.243.

PMID:
21079099

Supplemental Content

Support Center